-
Hyderabad is set to be the single largest concentration of Covid-19 vaccine manufacturing capacities globally
-
Hyderabad-based Dr Reddy’s Laboratories has collaborated with RDIF to import the first consignment of Sputnik-V while it is expected that the pharma giant will start manufacturing from its local facilities in India
-
RDIF CEO Kirill Dmitriev in a virtual press conference recently said he expected over 50 million doses of Sputnik V vaccine to be manufactured in India by this summer.
-
Govt must now work out a mutually agreeable pricing and procurement strategy for a smooth rollout of the foreign vaccines
-
According to the Hyderabad-based company, emergency use will be as per the provisions of the new drug and clinical trials rules, 2019 under the Drugs and Cosmetics Act
-
India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.
-
The decision comes after the Drugs Controller General of India (DCGI)'s SEC met today to take up Sputnik V application for EUA in India.
-
Four companies developing Covid vaccines in India are based in Hyderabad
-
Such a campaign was made by non-governmental organisations and media in the West, the outlets reported on Friday citing a high-ranking source in the Kremlin as saying.
-
I had a constructive call with Mihail Murashko (Mikhail Murashko), Russia's Health Minister, about the Covid19 response globally & in Russia, as well as about the Sputnik V vaccine & the WHO Emergency Use Listing process for vaccines.
-
As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21
-
Data on 19,866 volunteers were included in the efficacy analysis - 14,964 of whom received the vaccine and 4,902 the placebo.
-
The bridging phase II and phase III study on 1,600 subjects in India is assessing immunogenicity and safety.
-
Sputnik V is the third vaccine to be approved for the emergency use in the country, the report said.
-
The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India
-
Sputnik V, the world's first COVID-19 vaccine, is over 95 per cent effective, said Russian President Vladimir Putin on Thursday.
-
According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.
-
According to the experts, warning against alcohol consumption that has been issued is a general immune-boosting measure rather than as a specific contraindication or interaction with the vaccine.
-
The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.
-
According to the RDIF -- Russia's sovereign wealth fund, the vaccine's interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.